Edible Cannabis Product Exemption Application Process and Requirements
In order for a product to be considered for an edible cannabis product exemption, a licensed processor must meet the requirements of COMAR 10.62.37.21. On January 27, 2022, the MCA clarified the requirements under COMAR 10.62.37.21.C.(4). A copy of the resolution adopted by the MCA regarding edible cannabis product exemption requirements may be
viewed here.
List of Approved Products under COMAR 10.62.37.21
The MCA has voted on exempting certain products that meet the requirements of COMAR 10.62.37.21, as clarified through the resolution adopted at the meeting on January 27, 2022. The current list of products may be
viewed here. Note: this list will be updated as the MCA considers additional products.
Edible Cannabis Product Exemption Application
In order for the MCA to consider a request to exempt an edible cannabis product from COMAR 10.62.37.01-.19, a licensed processor must submit a complete edible cannabis product exemption application, including all required supporting documents. A complete application will be presented to the MCA for their consideration. A product may not be exempted unless approved by the MCA members in an open meeting. The application form may be
accessed here. Please direct any questions to
mca.product.approvals@maryland.gov.
MCA Fine Schedule
The document
linked here contains a list of civil money penalties approved by MCA on November 17, 2020, in accordance with COMAR 10.62.34.09.
Edible Cannabis Products
Regulations establishing the framework for the processing and distribution of edible cannabis products will be effective on April 19, 2021.
Packaging and Labeling
This guidance document provides information on new and updated requirements for the packaging and labeling of medical cannabis, including edible cannabis products.
Form and Dosage
Form and Dosage
This guidance document provides information on:
- Categorization of cannabis-infused products and edible cannabis products, and
- Restrictions on product form and dosage.
The guidance document provides information on (click here):
- The process, requirements, and restrictions for the transfer of an ownership interest and/or control of a medical cannabis license; and
- The required disclosures of ownership and control of a medical cannabis license.
Hemp Acquisition
Acquisition of Hemp – FAQs
- Pursuant to COMAR 10.62.22.03 and 10.62.28.03, licensed processors and dispensaries may obtain hemp from sources outside the seed-to-sale system (METRC) under certain circumstances.
- Additional information for obtaining hemp, as well as information on testing requirements, and the sale of CBD products can be found in the FAQs.
Clinical Director
Clinical Director Guidance Document
The guidance document provides information on:
- Who is eligible to serve as a clinical director;
- The responsibilities of a clinical director;
- Clinical director reporting and training requirements; and
- The process to register as a clinical director.
Video Surveillance, Inventory Control, and Inspections
Guidance Document
The guidance document provides information on:
- Video surveillance requirements for licensee premises;
- Theft and diversion reporting requirements; and
- Requirements for inventory tracking and entry of sales data.
